| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |